Latest News
Conference Coverage
‘Unheard of’ PAH improvement with novel drug: STELLAR
Sotatercept, a designer molecule that removes a key driver of pulmonary arterial hypertension, had efficacy and safety in the first of three...
Conference Coverage
Endurance exercise tied to more coronary atherosclerosis
Lifelong endurance athletes had more coronary plaques, including more noncalcified plaques, than fit and healthy individuals, according to a new...
Latest News
DEA proposals on telehealth for controlled substances draw fire
Both proposals would allow providers to prescribe a 30-day supply of a controlled substance or buprenorphine, but then require a face-to-face...
Conference Coverage
FREEDOM COVID: Full-dose anticoagulation cut mortality but missed primary endpoint
In an in-hospital anticoagulation trial, the primary COVID endpoint was missed but a survival benefit is observed.
Feature
Who can sue docs for wrongful death? Some states are trying to expand that group
Plus, the types of emotional damage that physicians can be sued for is expanding in pockets across the nation.
Feature
Telehealth doctor indicted on health care fraud, opioid distribution charges
According to court documents, Dr. Sangita Patel was responsible for submitting Medicare claims for improper telehealth visits she didn’t conduct...
From the Journals
Biologics show signs of delaying arthritis in psoriasis patients
Treatment with the interleukin-12/23 inhibitor ustekinumab or interleukin-23 inhibitors (guselkumab, risankizumab, tildrakizumab) was linked to a...
Feature
Specialty and age may contribute to suicidal thoughts among physicians
“The specialties with the highest reporting of physician suicidal thoughts are also those with the greatest physician shortages.”
Feature
Experts share real-world experience prescribing voclosporin, belimumab for lupus nephritis
While some rheumatologists expressed a treatment preference, patients with lupus nephritis tend to do well on both medications; however, cost and...
From the Journals
Call it preclinical or subclinical, ILD in RA needs to be tracked
Despite ILD being a leading cause of death in RA patients, there are no clinical guidelines for monitoring this lung condition in this population...
Conference Coverage
Bempedoic acid cuts CV events in statin-intolerant patients: CLEAR Outcomes
The CLEAR Outcomes trial establishes this new drug as an important addition to available nonstatin LDL cholesterol–lowering therapies, experts say...